FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to pharmacology, and concerns developing therapeutic agents possessing anti-retroviral activity. This agent represents a pharmaceutical composition containing an activated potentiated form of antibodies to immune protein or peptide reacting to HIV, or having the concentration and/or functional activity varying in relation to HIV infection.
EFFECT: developing the therapeutic agents possessing anti-retroviral activity.
11 cl, 2 ex
Authors
Dates
2014-12-10—Published
2010-08-06—Filed